Fig. 2
From: MYH6 suppresses tumor progression by downregulating KIT expression in human prostate cancer

MYH6 expression is associated with prostate cancer progression severity and prognosis. (A) MYH6 mRNA expression levels in prostate cancer samples from GDS1439 and GSE35988. One-way ANOVA was used. (B) ROC curves of MYH6 expression in prostate cancer patients. (C) Representative immunohistochemistry of MYH6 on benign prostate and prostate cancer tissues. (D) Kaplan–Meier survival curves for prostate cancer patients stratified by MYH6 expression.